Medicare Enrolled

Dr. Jennifer Braimon, MD

Endocrinology · Middleton, MA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
147 S MAIN ST, Middleton, MA 01949
9787742555
Registered in NPPES since 2006
NPI: 1649373986 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Braimon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Braimon? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Braimon

Dr. Jennifer Braimon is an endocrinology specialist in Middleton, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Braimon performed 10,210 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Braimon received a total of $4,543 from 26 pharmaceutical and/or device companies across 138 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Braimon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 3% volume in MA $4,543 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
10,210
Medicare services
Top 3% in MA for endocrinology
Not available
Unique patients (not deduplicated)
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 8,103 $18 $25
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
739 $93 $325
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
302 $137 $473
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
288 $9 $27
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
243 $27 $65
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
151 $11 $60
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
146 $130 $375
Ultrasound of head and neck soft tissue
This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation.
83 $38 $251
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
82 $20 $100
New patient office visit, complex (60-74 min) 41 $160 $450
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $48 $250
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
14 $26 $68
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,543
Total received (2018-2024)
Avg $649/year across 7 years
Top 29% in MA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
138
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,043
2023
$1,009
2022
$305
2021
$465
2020
$129
2019
$1,311
2018
$281

Payments by company (2024)

ABBVIE INC.
$280
Regeneron Healthcare Solutions, Inc.
$148
Novo Nordisk Inc
$102
Takeda Pharmaceuticals U.S.A., Inc.
$65
Medtronic, Inc.
$64
Abbott Laboratories
$58
Lilly USA, LLC
$55
Amgen Inc.
$40
Tandem Diabetes Care, Inc.
$39
GENZYME CORPORATION
$38
Dexcom, Inc.
$33
Radius Health, Inc.
$26
Janssen Biotech, Inc.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Madrigal Pharmaceuticals
$16
SANOFI-AVENTIS U.S. LLC
$16
Insulet Corporation
$14
Exact Sciences Corporation
$13
Top 3 companies account for 50.8% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic MiniMed, Inc.
$1,545
Amgen Inc.
$364
Novo Nordisk Inc
$283
ABBVIE INC.
$280
Astellas Pharma US Inc
$223
Tandem Diabetes Care, Inc.
$202
Lilly USA, LLC
$179
Regeneron Healthcare Solutions, Inc.
$164
Medtronic, Inc.
$155
Radius Health, Inc.
$150
Abbott Laboratories
$140
AbbVie Inc.
$114
Dexcom, Inc.
$111
AstraZeneca Pharmaceuticals LP
$91
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$86
Takeda Pharmaceuticals U.S.A., Inc.
$81
Janssen Biotech, Inc.
$71
SANOFI-AVENTIS U.S. LLC
$56
Antares Pharma, Inc.
$53
Zealand Pharma US, Inc.
$40
GENZYME CORPORATION
$38
LIFESCAN, INC.
$38
Insulet Corporation
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Madrigal Pharmaceuticals
$16
Exact Sciences Corporation
$13
Top 3 companies account for 48.2% of all-time payments
Associated products mentioned in payments ›
CREON · Cologuard Collection Kit · DUPIXENT · Dexcom G6 Transmitter · EMGALITY · ENTYVIO · EOHILIA · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Freedom Lite system · FreeStyle Libre 2 · GATTEX · Guardian Connect · InPen · JARDIANCE · LINZESS · MAVYRET · MINIMED 780G · MOUNJARO · Minimed 530G · Minimed 670G System · Myrbetriq · NOCDURNA · ONETOUCH VERIO REFLECT · Omnipod · Ozempic · RESMETIROM · RINVOQ · RYBELSUS · SKYRIZI · SOLIQUA 100/33 · STELARA · SYNTHROID · Saxenda · TRADJENTA · TREMFYA · TRULANCE · TRULICITY · TZIELD · Tymlos · V-GO · Veozah · XYOSTED · ZEGALOGUE · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in Middleton?
Compare endocrinologists in the Middleton area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
227
County median income
$99,431
Nearest hospital to ZIP centroid (approximate)
NORTHEAST HOSPITAL CORPORATION
7.6 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Braimon is a mixed practice specialist, with above-average Medicare volume (top 3% in MA), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Braimon experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Braimon performed 8,103 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Braimon receive payments from pharmaceutical companies?
Yes. Dr. Braimon received a total of $4,543 from 26 companies across 138 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Braimon's costs compare to other endocrinologists in Middleton?
Dr. Braimon's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Braimon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →